[1]刘 星,刘璟琰,张思宇.维生素C联合非布司他对高尿酸血症伴痛风患者sICAM-1及尿酸的影响[J].医学信息,2020,33(07):87-89.[doi:10.3969/j.issn.1006-1959.2020.07.024]
　LIU Xing,LIU Jing-yan,ZHANG Si-yu.Effects of Vitamin C Combined with Febuxostat on sICAM-1 and Uric Acid in Patients with Hyperuricemia and Gout[J].Medical Information,2020,33(07):87-89.[doi:10.3969/j.issn.1006-1959.2020.07.024]
点击复制

维生素C联合非布司他对高尿酸血症伴痛风患者sICAM-1及尿酸的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年07期
页码:
87-89
栏目:
论著
出版日期:
2020-04-01

文章信息/Info

Title:
Effects of Vitamin C Combined with Febuxostat on sICAM-1 and Uric Acid in Patients with Hyperuricemia and Gout
文章编号:
1006-1959（2020）07-0087-03
作者:
刘 星; 刘璟琰; 张思宇
（鞍钢集团总医院内分泌科，辽宁 鞍山 114000）
Author(s):
LIU Xing; LIU Jing-yan; ZHANG Si-yu
(Department of Endocrinology, Ansteel Group Hospital, Anshan 114000,Liaoning,China)
关键词:
高尿酸血症伴痛风; 维生素C; 非布司他; 别嘌呤醇; 血清可溶性细胞间粘附分子-1; 尿酸; 氧化应激反应
Keywords:
Hyperuricemia with gout; Vitamin C; Febuxostat; Allopurinol; Serum soluble intercellular adhesion molecule-1; Uric acid; Oxidative stress
分类号:
R511.5
DOI:
10.3969/j.issn.1006-1959.2020.07.024
文献标志码:
A
摘要:
目的 探讨维生素C联合非布司他对高尿酸血症伴痛风患者血清可溶性细胞间粘附分子-1（sICAM-1）及尿酸的影响。方法 选取我院2018年4月~2019年4月收治的78例高尿酸血症伴痛风患者，采用随机数字表法分为观察组以及对照组，各39例。两组均予以痛风定胶囊口服治疗，对照组在此基础上给予维生素C+别嘌呤醇口服治疗，观察组在此基础上给予维生素C+非布司他口服治疗，比较两组炎症因子[肿瘤坏死因子-α（TNF-α）、sICAM-1]水平、尿酸水平、氧化应激反应指标[晚期氧化蛋白产物（AOPP）、丙二醛（MDA）、血清超氧化物歧化酶（SOD）]水平及不良反应。结果 两组治疗6个疗程后TNF-α、sICAM-1、尿酸水平均较治疗前降低，且观察组低于对照组，差异有统计学意义（P＜0.05）；两组治疗前AOPP、MDA、SOD水平比较，差异无统计学意义（P＞0.05），两组治疗6个疗程后AOPP、MDA水平较治疗前降低，SOD水平较治疗前升高，且观察组AOPP、MDA水平低于对照组，SOD水平高于对照组，差异有统计学意义（P＜0.05）；观察组不良反应发生率为12.82%，低于对照组的7.69%，差异无统计学意义（P＞0.05）。结论 高尿酸血症伴痛风患者采用维生素C联合非布司治疗可有效降低炎性因子与尿酸水平，减轻机体氧化应激反应，且不会增加不良反应。
Abstract:
Objective To investigate the effect of vitamin C combined with febuxostat on serum soluble intercellular adhesion molecule-1(sICAM-1)and uric acid in patients with hyperuricemia and gout.Methods 78 patients with hyperuricemia and gout treated in our hospital from April 2018 to April 2019 were selected and divided into observation group and control group with random number table method,39 cases in each. Both groups were given oral treatment of Tongfengding capsules,and the control group was given oral treatment of vitamin C+allopurinol,and the observation group was given oral treatment of vitamin C+febuxostat on this basis,comparing inflammatory factors[tumor necrosis factor-α(TNF-α),sICAM-1]level,uric acid level,oxidative stress response index[late oxidation protein product(AOPP),malondialdehyde(MDA),serum superoxide dismutase (SOD)]level and Adverse reactions.Results After 6 courses of treatment,the levels of TNF-α,sICAM-1 and uric acid in the two groups were lower than before treatment,and the observation group was lower than the control group,the difference was statistically significant(P＜0.05),Before treatment,the levels of AOPP,MDA,and SOD between the two groups were not statistically significant(P＞0.05). After 6 courses of treatment,the levels of AOPP and MDA of the two groups were lower than before treatment,and the levels of SOD were higher than before treatment.AOPP and MDA levels were lower than the control group,SOD levels were higher than the control group,the difference was statistically significant(P＜0.05),the incidence of adverse reactions in the observation group was 12.82%,lower than 7.69% in the control group,the difference was not statistically significant(P＞0.05).Conclusion The treatment of hyperuricemia with gout patients with vitamin C combined with febuxostat can effectively reduce the levels of inflammatory factors and uric acid,reduce the body’s oxidative stress response,and will not increase adverse reactions.

参考文献/References:

[1]王国庆,邹延峰.高尿酸血症及痛风易感基因研究进展[J].安徽医药,2019,23(7):1280-1285.[2]祝开思,张彩香,林章梅.高尿酸血症患者血清胱抑素C和尿肝型脂肪酸结合蛋白水平及非布司他治疗痛风效果分析[J].临床内科杂志,2016,33(9):626-629.[3]中华医学会内分泌学分会.高尿酸血症和痛风治疗的中国专家共识[J].中华内分泌代谢杂志,2013,29(11):913-920.[4]周玥,陈建军,楼季庄,等.非布司他治疗痛风伴重度肾功能不全患者的疗效[J].江苏医药,2016,42(18):2038-2040.[5]张涛,王芳,张文涛,等.非布司他治疗痛风伴高尿酸血症患者的效果及其对血尿酸、TNF—α和sICAM-1水平的影响[J].广西医科大学学报,2017,34(8):1224-1226.[6]张文,解为慈,徐金娥,等.非布司他对痛风合并高尿酸血症患者血清sICAM-1,ET-1及尿酸水平的影响[J].现代生物医学进展,2016,16(27):5303-5305.[7]张立勋.90例痛风合并高尿酸血症患者应用非布司他的临床疗效及安全性分析[J].医药前沿,2016,6(24):62-63.[8]华明,孙朝珺.非布司他对比别嘌呤醇治疗慢性肾脏病合并高尿酸血症患者对于肾脏保护的作用[J].福建医科大学学报,2018,52(2):107-111.[9]孙海斌.尿酸减轻氧化应激诱导的血管内皮细胞损伤[J]. 中国动脉硬化杂志,2014,22(10):1019-1022.[10]张军霞,陈诚,张碧琳,等.别嘌呤醇对合并高尿酸血症的空腹血糖受损患者内皮功能的影响[J].中国糖尿病杂志,2016,8(10):618-622.[11]黄金沐,池慧琼,林少凯.比较非布司他片与别嘌呤醇片治疗高尿酸血症伴痛风的临床研究[J].中国临床药理学杂志,2017,33(20):2009-2012.[12]刘晓然,李泰明.黄嘌呤氧化酶抑制剂在高尿酸血症治疗中的研究进展[J].轻工科技,2017(9):20-21.[13]陈远翔,廖飞.血清尿酸测定中维生素C氧化酶抗干扰能力研究[J].国际检验医学杂志,2014(2):208-209,212.[14]姜珊,张丹娣.茶多酚和维生素C联合补充治疗高尿酸血症伴脂代谢异常患者的临床效果观察[J].河北医学,2017,23(10):1724-1729.[15]赵艳红.非布司他和别嘌呤醇治疗原发性痛风疗效和安全性的比较[J].浙江医学,2018,40(10):1088-1090.[16]陈士芳,许瑜佳,殷丽娟,等.非布司他治疗高尿酸血症、高脂血症患者血管内皮功能损伤的临床研究[J].中华内分泌外科杂志,2017,11(5):409-413.

相似文献/References:

[1]宋 蓉,陈晶晶,陈金凤,等.茵陈蒿汤联合维生素C对母儿ABO溶血的临床研究[J].医学信息,2018,31(10):145.[doi:10.3969/j.issn.1006-1959.2018.10.049]
　SONG Rong,CHEN Jing-jing,CHEN Jin-feng,et al.Clinical Study on the Effect of Yinchenhao Decoction Combined with Vitamin C on ABO Hemolysis in Mothers and Infants[J].Medical Information,2018,31(07):145.[doi:10.3969/j.issn.1006-1959.2018.10.049]
[2]魏 荣,黎友伦.维生素C在肺癌预防和治疗中的作用[J].医学信息,2019,32(16):44.[doi:10.3969/j.issn.1006-1959.2019.16.014]
　WEI Rong,LI You-lun.The Role of Vitamin C in the Prevention and Treatment of Lung Cancer[J].Medical Information,2019,32(07):44.[doi:10.3969/j.issn.1006-1959.2019.16.014]
[3]张 效.眼前节碱烧伤的治疗体会[J].医学信息,2020,33(06):189.[doi:10.3969/j.issn.1006-1959.2020.06.066]
　ZHANG Xiao.Experience in the Treatment of Alkali Burns in the Eyes[J].Medical Information,2020,33(07):189.[doi:10.3969/j.issn.1006-1959.2020.06.066]

更新日期/Last Update: 2020-04-01